Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app.
Anxiety and depression symptoms after COVID-19 infection: results from the COVID Symptom Study app.
复制标题
DOI:
10.1136/jnnp-2021-327565
复制
发表时间:
2021-12
期刊:
影响因子:
--
通讯作者:
Steves CJ
中科院分区:
文献类型:
--
作者:
Klaser K;Thompson EJ;Nguyen LH;Sudre CH;Antonelli M;Murray B;Canas LS;Molteni E;Graham MS;Kerfoot E;Chen L;Deng J;May A;Hu C;Guest A;Selvachandran S;Drew DA;Modat M;Chan AT;Wolf J;Spector TD;Hammers A;Duncan EL;Ourselin S;Steves CJ
Mental health issues have been reported after SARS-CoV-2 infection. However, comparison to prevalence in uninfected individuals and contribution from common risk factors (e.g., obesity, comorbidities) have not been examined. We identified how COVID-19 relates to mental health in the large community-based COVID Symptom Study. We assessed anxiety and depression symptoms using two validated questionnaires in 413,148 individuals between February and April 2021; 26,998 had tested positive for SARS-CoV-2. We adjusted for physical and mental pre-pandemic comorbidities, BMI, age, and sex. Overall, 26.4% of participants met screening criteria for general anxiety and depression. Anxiety and depression were slightly more prevalent in previously SARS-CoV-2 positive (30.4%) vs. negative (26.1%) individuals. This association was small compared to the effect of an unhealthy BMI and the presence of other comorbidities, and not evident in younger participants (≤40 years). Findings were robust to multiple sensitivity analyses. Association between SARS-CoV-2 infection and anxiety and depression was stronger in individuals with recent (<30 days) vs. more distant (>120 days) infection, suggesting a short-term effect. A small association was identified between SARS-CoV-2 infection and anxiety and depression symptoms. The proportion meeting criteria for self-reported anxiety and depression disorders is only slightly higher than pre-pandemic. Zoe Limited, National Institute for Health Research, Chronic Disease Research Foundation, National Institutes of Health, Medical Research Council UK
登录
查看更多内容
DOI:
10.1038/s41577-020-00458-y
发表时间:
2020-11
期刊:
Nature reviews. Immunology
影响因子:
--
作者:
Kreye J;Reincke SM;Prüss H
通讯作者:
Prüss H
影响因子:
38.1
作者:
Pezzini, Alessandro;Padovani, Alessandro
通讯作者:
Padovani, Alessandro
DOI:
10.1192/bjp.2020.212
发表时间:
2021-06
期刊:
The British journal of psychiatry : the journal of mental science
影响因子:
--
作者:
O'Connor RC;Wetherall K;Cleare S;McClelland H;Melson AJ;Niedzwiedz CL;O'Carroll RE;O'Connor DB;Platt S;Scowcroft E;Watson B;Zortea T;Ferguson E;Robb KA
通讯作者:
Robb KA
DOI:
10.1016/s2215-0366(20)30462-4
发表时间:
2021-03
期刊:
The lancet. Psychiatry
影响因子:
--
作者:
Taquet M;Luciano S;Geddes JR;Harrison PJ
通讯作者:
Harrison PJ
影响因子:
15.1
作者:
Raman B;Cassar MP;Tunnicliffe EM;Filippini N;Griffanti L;Alfaro-Almagro F;Okell T;Sheerin F;Xie C;Mahmod M;Mózes FE;Lewandowski AJ;Ohuma EO;Holdsworth D;Lamlum H;Woodman MJ;Krasopoulos C;Mills R;McConnell FAK;Wang C;Arthofer C;Lange FJ;Andersson J;Jenkinson M;Antoniades C;Channon KM;Shanmuganathan M;Ferreira VM;Piechnik SK;Klenerman P;Brightling C;Talbot NP;Petousi N;Rahman NM;Ho LP;Saunders K;Geddes JR;Harrison PJ;Pattinson K;Rowland MJ;Angus BJ;Gleeson F;Pavlides M;Koychev I;Miller KL;Mackay C;Jezzard P;Smith SM;Neubauer S
通讯作者:
Neubauer S